Aird & Berlis LLP
With extensive experience in a broad range of corporate finance and commercial matters, Jeffrey offers clients a practical and business-minded approach to solving legal and regulatory challenges. He is skilled at isolating what is truly important in a complex business transaction and in identifying solutions. Jeffrey takes great care in tailoring his service to each client and providing strategic and insightful judgment to effectively further their business objectives.
Jeffrey is co-Practice Group Leader of the firm's Capital Markets Group and co-Chair of the Life Sciences Group. He is also a member of the firm's Corporate/Commercial, Mergers & Acquisitions/Private Equity and International Groups, as well as the Cannabis and Mines & Minerals Groups. He practises corporate law with an emphasis on public and private financings, mergers and acquisitions, corporate governance and ongoing general corporate and commercial activities. Jeffrey’s experience includes numerous cross-border securities offerings (public and private), acting for U.S. buyers of Canadian entities or assets; acting for U.S. financiers of acquisitions in Canada; acting for Canadian sellers to U.S. buyers, and acting as Canadian counsel in connection with large, internationally-led transactions. He frequently advises mining, private equity, industrial, cannabis and psychedelics clients.
Jeffrey has recently been featured in the media with respect to the legal, regulatory and investment context for psychedelics in Canada.
In 2007, Jeffrey completed a six-month secondment with the Corporate Finance Branch of the Ontario Securities Commission where he was responsible for reviewing and clearing prospectuses and considering applications for relief from the requirements of the Securities Act (Ontario).